ReviewFrontiers in pharmacology2022

Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress.

Shunhao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.